Tracking study for anal cancer in people with and without HIV
Part of Cancer, Digestive system, Immune system & allergy, Infections clinical trials.
This study collects information from adults with anal squamous cell cancer, including people with HIV and without HIV. The goal is to better understand how treatments and outcomes may differ between these groups.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older
- You have a confirmed diagnosis of anal canal squamous cell cancer
- Blood tests must show whether you have HIV (you need recent HIV testing)
- You can be at any cancer stage
- You must have enough information about your treatments and outcomes to record in the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people living with HIV who may be at higher risk for anal cancer. It aims to better understand risk and outcomes, which could help guide future screening or prevention.
This study tests a self-collected anal swab for detecting HPV (the virus that can cause anal cancer) in people living with HIV. It aims to see if this simple swab is as accurate as a doctor-collected sample, and may help prevent anal cancer.
This study checks for early signs of anal cancer in women with HIV. It could help find problems before they become serious.
This study tries to prevent anal cancer in men who have sex with men and are at higher risk due to HIV or PrEP use. It uses a special exam called high-resolution anoscopy to check for early signs.
This study compares self-sampling (doing your own swab) to a healthcare professional doing the swab for HPV, a virus that can lead to anal cancer. It is for people with HIV on Réunion Island.
This study is screening gay and bisexual men for anal cancer by taking a swab sample. It aims to find early signs of cancer so it can be treated early.
Hear when a new Anal Squamous Cell Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.